HIV mutation literature information.


  Drug resistance evolution in patients with human immunodeficiency virus-1 under long-term antiretroviral treatment-failure in Yunnan Province, China.
 PMID: 30621727       2019       Virology journal
Abstract: Furthermore, L10 V/F/I (6.82%), A71V (4.55%), and I54V (4.55%) mutations were common in protease inhibitors (PIs).
Result: The PI mutations most commonly found were L10 V/F/I, A71V, and I54V, with DR rates of 6.82, 4.55, and 4.55%, respectively.
Discussion: L10 V/F/I had the highest rate (up to 6.82%).


  HIV-1 infection among crack cocaine users in a region far from the epicenter of the HIV epidemic in Brazil: Prevalence and molecular characteristics.
 PMID: 30016324       2018       PloS one
Abstract: Five isolates had secondary mutations to protease inhibitors (K20M, L10V, L33I, A71T, A71V).
Result: No major mutation to PI was identified; however, five isolates presented minor PI mutations (K20M: BRGO_CK4, subtype B; A71V: BRGO_CK600, subtype B; L10V: BRGO_CK496, subtype B; A71T and L33I: BRGO_CK311, subtype B; L10V: BRGO_CK117, subtype C).


  HIV Reverse Transcriptase and Protease Genes Variability Can Be a Biomarker Associated with HIV and Hepatitis B or C Coinfection.
 PMID: 29844604       2018       Scientific reports
Discussion: 4 included patient 98_co (HIV/HBV) with resistance codon E138A; patient 100_co (HIV/HBV) with codons L10A and L10V; and patient 105_co (HIV/HBV) with codon K103E.
Discussion: Additionally, the patient had the L10V, M41L and T215E resistance codons.
Discussion: Although the mutation L10V is an accessory mutation to PI, the mutations M41L and T215E are associated with resistance to NNRTI, and are therefore associated with cross resistance.


  Virological response, HIV-1 drug resistance mutations and genetic diversity among patients on first-line antiretroviral therapy in N'Djamena, Chad: findings from a cross-sectional study.
 PMID: 29126456       2017       BMC research notes
Result: Minor mutations found were mainly polymorphisms: K20I/M (21), L10I/V (15), L90W (1), L76S (1), N88D (1), V11I (1), V32L (1) and G48R (1).


  Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaounde, Cameroon.
 PMID: 29074854       2017       Scientific reports
Table: L10V


  The infection staging and profile of genotypic distribution and drug resistance mutation among the human immunodeficiency virus-1 infected blood donors from five Chinese blood centers, 2012-2014.
 PMID: 28622345       2017       PloS one
Discussion: Perhaps a result that some polymorphic accessory mutations such as: A71V/T and L10I/V on PIs; V106I and V90I on NNRTIs, commonly observed in previous studies, were no longer classified as PI minor DRMs and NNRTI resistance mutations in the updated Stanford HIVdb Program Genotypic Resistance Interpretation Algorithm (HIVdb version 8.3).


  HIV-1 Epidemiology, Genetic Diversity, and Primary Drug Resistance in the Tyumen Oblast, Russia.
 PMID: 27957489       2016       BioMed research international
Abstract: A high incidence of CXCR4-tropic HIV-1 variants and a higher rate of secondary mutations influencing the virus fitness (K20R, L10V, and I) are observed among the virus specimens isolated from newly infected individuals.
Result: The mutations able to improve HIV-1 reproductive characteristics in the presence of PIs or decrease the PI sensitivity (K20R, T74S, L10V/I, and K20I) were most frequently recordable among the examined HIV-1 variants, mainly in the individuals infected in 2010-2015.


  Cross-sectional study of virological failure and multinucleoside reverse transcriptase inhibitor resistance at 12 months of antiretroviral therapy in Western India.
 PMID: 27631260       2016       Medicine
Result: Only 1 individual had major PI resistance mutation L90M and 5 had minor PI resistance mutations L89M, V77I, L63P, H69K/R/Q, M36I, K20I/M/R/T, G16E, and L10V/I.


  Binding of Clinical Inhibitors to a Model Precursor of a Rationally Selected Multidrug Resistant HIV-1 Protease Is Significantly Weaker Than That to the Released Mature Enzyme.
 PMID: 27039930       2016       Biochemistry
Result: Conservative substitutions L10V and L10I in PR22 and PRS17 respectively, are classified as minor resistance mutations.


  Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance.
 PMID: 26870021       2016       Frontiers in microbiology
Table: L10V



Browser Board

 Co-occurred Entities




   Filtrator